AstraZeneca’s announcement is part of a $50 billion commitment to new U.S. facilities by 2030, much like the tens of billions in spending recently announced by Roche, Novartis, and Sanofi—and ...

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.

AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030. It said the "cornerstone ...

AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030. The bulk of the funds will go toward building a plan that ...

AstraZeneca investing $50B in US, Trump calls it an ‘honor’ by Joseph Choi - 07/22/25 2:32 PM ET ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to the United States, the Times reported on Tuesday, citing multiple sources.

In today’s CEO Daily: Diane Brady talks to AstraZeneca CEO Pascal Soriot. The big story: Trump punishes the WSJ for its Epstein scoop. The markets: Low drama. Analyst notes from Deutsche Bank on ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington. A large chunk of the funds will ...